Back
West Pharmaceutical Services, I (WST)
Life Sciences Tools & ServicesWST · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$353.08
−0.20%Weekly undervalued picks
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$6.79
ROE
19.1%
Gross margin
36.3%
Debt/Equity
0.11x
Revenue growth
21.0%
West Pharmaceutical Services, I — company intelligence
Earnings surprises
Q2 2026$2.37 vs $2.10 est+12.8%
Q1 2026$2.13 vs $1.69 est+25.8%
Q4 2025$2.04 vs $1.85 est+10.2%
Q3 2025$1.96 vs $1.70 est+15.4%
Analyst consensus · 22 analysts
20 Buy2 Hold0 Sell
Updated Jul 20, 2026
Insider activity · 90 days
1 buy0 sellsnet +46 shares
HAUGEN JANET BRUTSCHEABuy 46 · Jun 30, 2026
Recent SEC filings
4 — Insider transaction reportAug 12, 2026
10-Q — Quarterly reportJul 23, 2026
8-K — Material event reportJul 23, 2026
Latest news
Here's Why You Should Add INSP Stock to Your Portfolio Now — Yahoo · 5d ago
SNN Advances Surgical Robotics Through Imperial College Partnership — Yahoo · 6d ago
Smith+Nephew Launches FLOW FLEXTEND COBLATION Wand for Hip Surgery — Yahoo · 1w ago
Here's Why You Should Retain CONMED Stock in Your Portfolio Now — Yahoo · 1w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.